Cervical cancer: A global health crisis.
Cancer
; 123(13): 2404-2412, 2017 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-28464289
ABSTRACT
Cervical cancer is the fourth most common malignancy diagnosed in women worldwide. Nearly all cases of cervical cancer result from infection with the human papillomavirus, and the prevention of cervical cancer includes screening and vaccination. Primary treatment options for patients with cervical cancer may include surgery or a concurrent chemoradiotherapy regimen consisting of cisplatin-based chemotherapy with external beam radiotherapy and brachytherapy. Cervical cancer causes more than one quarter of a million deaths per year as a result of grossly deficient treatments in many developing countries. This warrants a concerted global effort to counter the shocking loss of life and suffering that largely goes unreported. This article provides a review of the biology, prevention, and treatment of cervical cancer, and discusses the global cervical cancer crisis and efforts to improve the prevention and treatment of the disease in underdeveloped countries. Cancer 2017;1232404-12. © 2017 American Cancer Society.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brachytherapy
/
Carcinoma, Squamous Cell
/
Uterine Cervical Neoplasms
/
Cisplatin
/
Papillomavirus Infections
/
Papillomavirus Vaccines
/
Hysterectomy
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Screening_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Cancer
Year:
2017
Document type:
Article